The Medical Affairs Transformation capabilities within PwC’s Pharmaceutical and Life Sciences Group have been developed specific to the unique needs of Medical Affairs. With unprecedented shifts in the landscape impacting patient care, biopharma’s dependence on medical affairs to sustain patient centricity has never been more important. Coupled with health care providers’ growing reliance on medical affairs for the latest evidence, insights, knowledge, and opportunities to conduct research in the real world, medical affairs transformation is moving forward at a fast pace. This fast-paced transformation necessitates non-traditional approaches, leveraging technology to unlock value, achieve efficiencies, and uphold scientific credibility, business acumen, and compliance.